Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
LM-302
LaNova Medicines Limited
Advanced Solid Tumor
1 trial -
LN-145
Iovance Biotherapeutics B.V.
Metastatic Non Small Cell Lung Cancer
1 trial -
LN-145
Iovance Biotherapeutics B.V.
Cervical Carcinoma
1 trial -
LN-145
Iovance Biotherapeutics B.V.
Cutaneous Squamous Cell Carcinoma
1 trial -
LN-145
Iovance Biotherapeutics B.V.
Squamous Cell Carcinoma of the Head and Neck
1 trial -
LN-145
Iovance Biotherapeutics B.V.
Non Small Cell Lung Cancer
1 trial -
LOLA trial
Fondazione Telethon ETS
gastroenteropancreatic (GEP) and thoracic neuroendocrine tumor (NET)
1 trial -
LOTS-GC-01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
LOXO-BTK-18001 BRUIN
Wuhan Createrna Science and Technology Co., Ltd
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Non-Hodgkin Lymphoma (NHL)"
1 trial -
LOXO-RAS-20001
Eli Lilly Co.
KRAS G12C-Mutant Advanced Solid Tumors
1 trial -
LOXO-RET-18036
Wuhan Createrna Science and Technology Co., Ltd
Pediatric Patients with Advanced RET-Altered Solid or Primary Central Nervous System Tumors
1 trial -
LTS17704
Sanofi-aventis Healthcare Pty Ltd
Cancer
1 trial -
LY2157299
Eli Lilly and Company
Carcinoma, Hepatocellular
1 trial -
LY2875358, ERLOTINIB
Eli Lilly Co.
Non-Small Cell Lung Cancer
1 trial -
Lacutamab
Lacuna Pharma Pty Ltd
Advanced T-Cell Lymphomas (TCL), i.e. Cutaneous T Cell Lymphomas (CTCL) CTCL subtypes under investigation: relapsed/refractory Sézary Syndrome (SS), stage IB to IV Mycosis Fungoides (MF).
1 trial -
Lapatinib
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Lenalidomide
United Therapeutics Europe Ltd
Recurrent Mantle Cell Lymphoma
1 trial -
Lenalidomide [Leavdo®]
Hospital Authority, Hong Kong
Antibiotics-unresponsive MALT Lymphoma
1 trial -
Lenalidomide and Gemcitabine (Dose level 11)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral T-cell Lymphomas (PTCL)
1 trial -
Lenalidomide combined with G-CHOP (LO CHOP)
The First People's Hospital of Lianyungang
DLBCL - Diffuse Large B Cell Lymphoma
1 trial -
Lenvatinib
The First People's Hospital of Lianyungang
Biliary Tract Cancer
1 trial -
Lenvatinib
United Therapeutics Europe Ltd
Columnar Cell Variant Thyroid Gland Papillary Carcinoma
1 trial -
Lenvatinib
Eisai Co.,
Osteosarcoma
1 trial -
Lenvima 4 mg Oral Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma (HCC)
1 trial -
Letrozole
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uterine Cervical Neoplasms
1 trial -
Letrozole
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Leucovorin
Cardiff Oncology
Colorectal Cancer
1 trial -
Leukine for Ovarian cancer
Nordic Bioscience A/S
Ovarian cancer
1 trial -
Leuprolide or goserelin
NORTHWEST BIOTHERAPEUTICS INC
Cancer
1 trial -
Leuprorelin
Takeda
Prostatic Neoplasms
1 trial -
Levact 2 for Relapsed/refractory large B-cel…
The George Institute
Relapsed/refractory large B-cell non-Hodgkin lymphoma, mantle cell lymphoma, and follicular lymphoma
1 trial -
Lifileucel
Iovance Biotherapeutics B.V.
Metastatic Melanoma
2 trials -
Lifileucel
Iovance Biotherapeutics B.V.
Endometrial Cancer
1 trial -
Lifileucel
Iovance Biotherapeutics B.V.
Melanoma (Skin Cancer)
1 trial -
Light-activated AU-011
Aura Biosciences
Uveal Melanoma
1 trial -
Linperlisib combination with obinutuzumab
The First People's Hospital of Lianyungang
Lymphoma
1 trial -
Lintuzumab-Ac225
Actinium Pharmaceuticals
Acute Myeloid Leukemia
2 trials -
Liposomal Annamycin
Moleculin Biotech
Leukemia, Myeloid, Acute
3 trials -
Liposomal Annamycin (L-Annamycin)
Moleculin Biotech
Sarcoma,Soft Tissue
1 trial -
Liposomal Irinotecan
United Therapeutics Europe Ltd
Oncology
1 trial -
Liposomal doxorubicin hydrochloride
Teva Pharma GmbH
Breast Cancer
1 trial -
Liposomal irinotecan
The First People's Hospital of Lianyungang
Pancreatic Ductal Adenocarcinoma
1 trial -
Liposome-encapsulated Daunorubicin-Cytarabine
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
1 trial -
Liposome-encapsulated Daunorubicin-Cytarabine
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
2 trials -
Lipotecan
Taiwan Liposome Company
HepatoCellular Carcinoma
1 trial -
Lisocabtagene maraleucel
Celgene Europe Limited
Relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma (NHL)
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
Relapsed Follicular Lymphoma
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
Diffuse Large B-cell Lymphoma
4 trials
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.